Manchester Capital Management’s AtriCure ATRC Stock Holding History

Manchester Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35	Closed	-$1.73K	–	1011
2023 Q2	$1.73K	Sell	35 -53	-60%	-$2.44K	﹤0.01%	759
2023 Q1	$3.65K	Hold	88	–	–	﹤0.01%	672
2022 Q4	$3.9K	Buy	88 +53	+151%	+$2.21K	﹤0.01%	573
2022 Q3	$1K	Sell	35 -236	-87%	-$10.8K	﹤0.01%	719
2022 Q2	$11K	Hold	271	–	–	﹤0.01%	470
2022 Q1	$18K	Sell	271 -237	-47%	-$15.4K	﹤0.01%	475
2021 Q4	$35K	Hold	508	–	–	﹤0.01%	422
2021 Q3	$35K	Buy	508 +473	+1,351%	+$36.4K	﹤0.01%	455
2021 Q2	$3K	Buy	+35	New	+$2.54K	﹤0.01%	617

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Manchester Capital Management's ATRC Position: Q3 2023 in Review

Manchester Capital Management sold out of AtriCure (ATRC) in Q3 2023, closing a stake of 35 shares — an estimated $1.73K sold.

Manchester Capital Management first reported a position in ATRC in Q2 2021 and held it in 9 quarters. The position peaked at $35K in Q4 2021. 230 funds tracked by Wall St. Rank hold ATRC as of Q3 2023.

Manchester Capital Management reported no remaining AtriCure position as of Q3 2023 after selling out during the quarter.
Manchester Capital Management sold 35 AtriCure shares in Q3 2023, an estimated $1.73K.
Manchester Capital Management first reported a position in AtriCure in Q2 2021 and held it in 9 quarters.
Manchester Capital Management's AtriCure position peaked at $35K in Q4 2021.
230 funds tracked by Wall St. Rank held AtriCure as of Q3 2023.

Based on Manchester Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.